机译:可溶性PD-1的疫苗靶向MUC1 VNTR和Survivin改善了抗肿瘤作用
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
National Engineering Laboratory for AIDS Vaccine College of Life Science Jilin University;
Soluble PD-1; Cancer vaccine; MUC1; Survivin; Anti-tumor immunity;
机译:可溶性PD-1的疫苗靶向MUC1 VNTR和Survivin改善了抗肿瘤作用
机译:Doxorubicin预处理增强FAPα/ Survivin共靶向DNA疫苗抗肿瘤活性,主要通过在4T1鼠乳腺癌模型中的外周MDSC减少
机译:Doxorubicin预处理增强了Fapalpha / Survivin共靶向DNA疫苗抗肿瘤活性,主要通过在4T1鼠乳腺癌模型中的外周MDSC减少
机译:通过靶向异常表达的自我抗原来预防癌症:用于预防上皮腺癌的MUC1疫苗
机译:靶向CD40的腺病毒作为抗肿瘤疫苗
机译:阿霉素预处理主要通过降低4T1鼠乳腺癌模型中的外周MDSCs来增强FAPα/ survivin共靶向DNA疫苗的抗肿瘤活性
机译:Doxorubicin预处理增强FAPα/ Survivin共靶向DNA疫苗抗肿瘤活性,主要通过降低4T1鼠乳腺癌模型中的外周MDSC